April 19th 2024, 3:00pm
From the Allman Brothers Band’s singer Dickey Betts dying after a cancer diagnosis to the “Shopaholic” author announcing her glioblastoma diagnosis, here’s what is happening in the cancer space this week.
April 18th 2024, 7:00pm
Topline data has been released from a trial of antibody-drug conjugate FG-3246 for patients with pretreated, metastatic castration-resistant prostate cancer.
April 18th 2024, 3:00pm
For decades, researchers have been seeking a therapy to improve outcomes for patients with clear cell renal cell carcinoma who underwent a nephrectomy.
April 15th 2024, 7:00pm
Compared to other treatments, patients’ testosterone levels return to baseline levels faster following treatment with Orgovyx.
April 10th 2024, 5:00pm
Anxiety over scans makes sense, but isn’t there more anxiety about other cancer tests, too?
April 9th 2024, 7:00pm
Patients with prostate cancer receiving ADT who are vitamin D deficient may receive the most bone density benefits from high-dose vitamin D.
April 8th 2024, 10:00pm
When experiencing loss, always look forward and have hope.
April 5th 2024, 7:00pm
Since January 2024, the Food and Drug Administration has approved several treatments and combinations for solid tumors.
April 4th 2024, 9:00pm
Treatment with immune checkpoint inhibitors has improved survival outcomes for patients with metastatic bladder cancer, compared with chemotherapy.
March 28th 2024, 7:00pm
Across disease stages, Black patients with renal cell carcinoma experience worse survival outcomes than White patients, research has shown.
More Than a Cyst: The Fear Cancer Leaves Behind
Basics of Squamous Cell Bladder Cancer
AVZO-103 Wins FDA Designation for Previously Treated Urothelial Cancer
Expert Explains Recent Advances in Early Stage Lung Cancer Surgery